产品标题 产品货号 产品规格 厂家
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5600655 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5603995 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5608155 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5614045 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5620515 ugORIGENE TECHNOLOGIES
Human RNA: Ovary-Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR566312n/aORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5630355 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenofibroma of ovary from ORIGENE TECHNOLOGIESCR5597845 ugORIGENE TECHNOLOGIES
Human RNA: Ovary; Adenofibroma of ovary from ORIGENE TECHNOLOGIESCR5629515 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, clear cell from ORIGENE TECHNOLOGIESCR5621435 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, endometrioid, papillary serous from ORIGENE TECHNOLOGIESCR5625635 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, endometrioid, serous from ORIGENE TECHNOLOGIESCR5602445 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, mucinous from ORIGENE TECHNOLOGIESCR5613025 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5594255 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5601045 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5602395 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5607245 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5609925 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5612325 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5619785 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5621955 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5624405 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5624905 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5626255 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5626265 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5630005 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5630015 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, papillary serous, metastatic from ORIGENE TECHNOLOGIESCR5601065 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5600875 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5624715 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5624805 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5624815 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5624895 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous from ORIGENE TECHNOLOGIESCR5626285 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR5603005 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral-Adenocarcinoma of ovary, serous, metastatic from ORIGENE TECHNOLOGIESCR566311n/aORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Carcinoma of ovary from ORIGENE TECHNOLOGIESCR5600935 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Carcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5590665 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Carcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5602465 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Carcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5612055 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Carcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5605825 ugORIGENE TECHNOLOGIES
Human RNA: Ovary: bilateral; Carcinoma of ovary, papillary serous from ORIGENE TECHNOLOGIESCR5613075 ugORIGENE TECHNOLOGIES
Nfxl1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5109561 kitORIGENE TECHNOLOGIES
NFYA - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4059811 kitORIGENE TECHNOLOGIES
Nfya - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5109571 kitORIGENE TECHNOLOGIES
NFYB - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4027491 kitORIGENE TECHNOLOGIES
Nfyb - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5109581 kitORIGENE TECHNOLOGIES
NFYB Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30274910 ugORIGENE TECHNOLOGIES
NFYC - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4000601 kitORIGENE TECHNOLOGIES
Nfyc - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5109591 kitORIGENE TECHNOLOGIES
 |< < 5392 5393 5394 5395 5396 5397 5398 5399 5400 > >| 第 5400/6274 页